Atovaquone Glenmark

Atovaquone Glenmark is an oral medication used to treat and prevent certain parasitic infections. This antimalarial drug is effective in managing conditions like Pneumocystis pneumonia.

Atovaquone Glenmark is primarily used to treat and prevent Pneumocystis pneumonia, a type of lung infection caused by a parasite. It is also used to treat malaria, particularly in cases where other treatments are not suitable. The medication works by stopping the growth of the parasites that cause these infections.

Common effects of Atovaquone Glenmark may include nausea, vomiting, diarrhea, and stomach pain. Some users might experience headache, dizziness, or rash. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider.

Atovaquone Glenmark should be used with caution in individuals with liver or kidney problems. It is important to follow the prescribed dosage and complete the full course of treatment. Avoid taking this medication if you are allergic to any of its components. Always consult a healthcare provider before starting any new medication.

Atovaquone Glenmark may interact with certain medications, including antacids, metoclopramide, and drugs that affect liver enzymes. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol should be avoided while taking this medication.